THE REATA MISSION
At Reata Pharmaceuticals, our mission is to develop innovative therapies that change patients’ lives for the better.
At Reata Pharmaceuticals, our mission is to develop innovative therapies that change patients’ lives for the better.
Reata is focused on developing novel therapies for life threatening diseases that have few or no treatment options…
Learn More
Nrf2 activators exhibit broad, anti-inflammatory, anti-fibrotic, and promitochondrial activity in vitro and have many potential clinical applications1-3…
Learn More
Our product candidates have the potential to treat patients with high unmet medical need…
Learn More
Reata’s development programs have created a robust pipeline of drug candidates for the treatment of serious, life-threatening diseases. Find out more here.
Omav=omaveloxolone; Bard=bardoxolone methyl; ADPKD=autosomal dominant polycystic kidney disease